{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Oximacro\u00ae", "PAC-A2", "antiviral and virucidal activities", "cranberry extract", "dimeric A-type proanthocyanidins", "hemagglutinin", "influenza virus"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30131793", "DateRevised": {"Year": "2023", "Month": "11", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "08", "Day": "07"}], "Language": ["eng"], "ELocationID": ["1826", "10.3389/fmicb.2018.01826"], "Journal": {"ISSN": "1664-302X", "JournalIssue": {"Volume": "9", "PubDate": {"Year": "2018"}}, "Title": "Frontiers in microbiology", "ISOAbbreviation": "Front Microbiol"}, "ArticleTitle": "The Cranberry Extract Oximacro<sup>\u00ae</sup> Exerts <i>in vitro</i> Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin.", "Pagination": {"StartPage": "1826", "MedlinePgn": "1826"}, "Abstract": {"AbstractText": ["The defense against influenza virus (IV) infections still poses a series of challenges. The current antiviral arsenal against influenza viruses is in fact limited; therefore, the development of new anti-influenza strategies effective against antigenically different viruses is an urgent priority. Bioactive compounds derived from medicinal plants and fruits may provide a natural source of candidates for such broad-spectrum antivirals. In this regard, cranberry (<i>Vaccinium macrocarpon</i> Aiton) extracts on the basis of their recognized anti-adhesive activities against bacteria, may provide potential compounds able to prevent viral attachment to target cells. Nevertheless, only few studies have so far investigated the possible use of cranberry extracts as an antiviral tool. This study focuses on the suitability of a cranberry extract as a direct-acting anti-influenza compound. We show that the novel cranberry extract Oximacro<sup>\u00ae</sup> inhibits influenza A and B viruses (IAV, IBV) replication <i>in vitro</i> because of its high content of A-type proanthocyanidins (PAC-A) dimers and trimers. Mechanistic studies revealed that Oximacro<sup>\u00ae</sup> prevents attachment and entry of IAV and IBV into target cells and exerts a virucidal activity. Oximacro<sup>\u00ae</sup> was observed to interact with the ectodomain of viral hemagglutinin (HA) glycoprotein, thus suggesting the interference with HA functions and a consequent loss of infectivity of IV particles. Fluorescence spectroscopy revealed a reduction in the intrinsic fluorescence of HA protein after incubation with purified dimeric PAC-A (PAC-A2), thus confirming a direct interaction between HA and Oximacro<sup>\u00ae</sup> PAC-A2. <i>In silico</i> docking simulations further supported the <i>in vitro</i> results and indicated that among the different components of the Oximacro<sup>\u00ae</sup> chemical profile, PAC-A2 exhibited the best binding propensity with an affinity below 10 nM. The role of PAC-A2 in the anti-IV activity of Oximacro<sup>\u00ae</sup> was eventually confirmed by the observation that it prevented IAV and IVB replication and caused the loss of infectivity of IV particles, thus indicating PAC-A2 as the major active component of Oximacro<sup>\u00ae</sup>. As a whole, these results suggest Oximacro<sup>\u00ae</sup> as a potential candidate to create novel antiviral agents of natural origin for the prevention of IV infections."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Microbiology and Virology, Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy."}], "LastName": "Luganini", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Microbiology and Virology, Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy."}], "LastName": "Terlizzi", "ForeName": "Maria E", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Laboratory, Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy."}], "LastName": "Catucci", "ForeName": "Gianluca", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Laboratory, Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy."}], "LastName": "Gilardi", "ForeName": "Gianfranco", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Plant Physiology Laboratory, Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy."}], "LastName": "Maffei", "ForeName": "Massimo E", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Microbiology and Virology, Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy."}], "LastName": "Gribaudo", "ForeName": "Giorgio", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Microbiol", "NlmUniqueID": "101548977", "ISSNLinking": "1664-302X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Alame M. M., Massaad E., Zakaret H. (2016). Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections. Front. Microbiol. 7:450. 10.3389/fmicb.2016.00450", "ArticleIdList": ["10.3389/fmicb.2016.00450", "PMC4815007", "27065996"]}, {"Citation": "Bahramsoltani R., Sodagari H. R., Farzaei M. H., Abdolghaffari A. H., Gooshe M., Rezaei N. (2016). The preventive and therapeutic potential of natural polyphenols on influenza. Expert Rev. Anti Infect. Ther. 14 57\u201380. 10.1586/14787210.2016.1120670", "ArticleIdList": ["10.1586/14787210.2016.1120670", "26567957"]}, {"Citation": "Blumberg J. B., Camesano T. A., Cassidy A., Kris-Etherton P., Howell A., Manach C., et al. (2013). Cranberries and their bioactive constituents in human health. Adv. Nutr. 4 618\u2013632. 10.3945/an.113.004473", "ArticleIdList": ["10.3945/an.113.004473", "PMC3823508", "24228191"]}, {"Citation": "Catucci G., Gilardi G., Jeuken L., Sadeghi S. J. (2012). In vitro drug metabolism by C-terminally truncated human flavin-containing monooxygenase 3. Biochem. Pharmacol. 83 551\u2013558. 10.1016/j.bcp.2011.11.029", "ArticleIdList": ["10.1016/j.bcp.2011.11.029", "22177984"]}, {"Citation": "Charlton A. J., Baxter N. J., Khan M. L., Moir A. J., Haslam E., Davies A. P., et al. (2002). Polyphenol/peptide binding and precipitation. J. Agric. Food Chem. 50 1593\u20131601. 10.1021/jf010897z", "ArticleIdList": ["10.1021/jf010897z", "11879042"]}, {"Citation": "Derksen A., Hensel A., Hafezi W., Herrmann F., Schmidt T. J., Ehrhardt C., et al. (2014). 3-O-Galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus. PLoS One 9:e110089. 10.1371/journal.pone.0110089", "ArticleIdList": ["10.1371/journal.pone.0110089", "PMC4193892", "25303676"]}, {"Citation": "Droebner K., Ehrhardt C., Poetter A., Ludwig S., Planz O. (2007). CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. 76 1\u201310. 10.1016/j.antiviral.2007.04.001", "ArticleIdList": ["10.1016/j.antiviral.2007.04.001", "17573133"]}, {"Citation": "Ebraihimnejad H., Burkholz T., Jacob C. (2014). \u201cFlavanols and proanthocyanidins,\u201d in Recent Advances in Redox Active Plant and Microbial Products, eds Jacob C., Kirsch G., Slusarenko A., Winyard P. G., Burkholz T. (London: Springer; ), 211\u2013234."}, {"Citation": "Gamblin S. J., Haire L. F., Russell R. J., Stevens D. J., Xiao B., Ha Y., et al. (2004). The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303 1838\u20131842. 10.1126/science.1093155", "ArticleIdList": ["10.1126/science.1093155", "14764886"]}, {"Citation": "Gangehei L., Ali M., Zhang W., Chen Z., Wakame K., Haidari M. (2010). Oligonol a low molecular weight polyphenol of lychee fruit extract inhibits proliferation of influenza virus by blocking reactive oxygen species-dependent ERK phosphorylation. Phytomedicine 17 1047\u20131056. 10.1016/j.phymed.2010.03.016", "ArticleIdList": ["10.1016/j.phymed.2010.03.016", "20554190"]}, {"Citation": "Gao C. L., Catucci G., Di Nardo G., Gilardi G., Sadeghi S. J. (2016). Human flavin-containing monooxygenase 3: structural mapping of gene polymorphisms and insights into molecular basis of drug binding. Gene 593 91\u201399. 10.1016/j.gene.2016.08.020", "ArticleIdList": ["10.1016/j.gene.2016.08.020", "27523475"]}, {"Citation": "Ge H., Wang Y. F., Xu J., Gu Q., Liu H. B., Xiao P. G., et al. (2010). Anti-influenza agents from traditional Chinese medicine. Nat. Prod. Rep. 27 1758\u20131780. 10.1039/c0np00005a", "ArticleIdList": ["10.1039/c0np00005a", "20941447"]}, {"Citation": "Gon\u00e7alves R., Mateus N., de Freitas V. (2010a). Biological relevance of the interaction between procyanidins and trypsin: a multitechnique approach. J. Agric. Food Chem. 58 11924\u201311931. 10.1021/jf1023356", "ArticleIdList": ["10.1021/jf1023356", "21047067"]}, {"Citation": "Gon\u00e7alves R., Mateus N., de Freitas V. (2010b). Study of the interaction of pancreatic lipase with procyanidins by optical and enzymatic methods. J. Agric. Food. Chem. 58 11901\u201311906. 10.1021/jf103026x", "ArticleIdList": ["10.1021/jf103026x", "21028873"]}, {"Citation": "Govorkova E. A. (2013). Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses. Influenza Other Respir. Viruses. 7 50\u201357. 10.1111/irv.12044", "ArticleIdList": ["10.1111/irv.12044", "PMC4942988", "23279897"]}, {"Citation": "Govorkova E. A., McCullers J. A. (2013). Therapeutics against influenza. Curr. Top. Microbiol. Immunol. 370 273\u2013300. 10.1007/82_2011_198", "ArticleIdList": ["10.1007/82_2011_198", "PMC7121838", "22246228"]}, {"Citation": "Grienke U., Richter M., Walther E., Hoffmann A., Kirchmair J., Makarov V., et al. (2016). Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae. Sci. Rep. 6:27156. 10.1038/srep27156", "ArticleIdList": ["10.1038/srep27156", "PMC4891693", "27257160"]}, {"Citation": "Gupta K., Chou M. Y., Howell A., Wobbe C., Grady R., Stapelton A. E. (2007). Cranberry products inhibit adherence of uropathogenic escherichia coli to primary cultured bladder and vaginal epithelial cells. J. Urol. 177 2357\u20132360. 10.1016/j.juro.2007.01.114", "ArticleIdList": ["10.1016/j.juro.2007.01.114", "PMC3684265", "17509358"]}, {"Citation": "Ha S. Y., Youn H., Song C. S., Kang S. C., Bae J. J., Kim K. M., et al. (2014). Antiviral effect of flavonol glycosides isolated from the leaf of Zanthoxylum piperitum on influenza virus. J. Microbiol. 52 340\u2013344. 10.1007/s12275-014-4073-5", "ArticleIdList": ["10.1007/s12275-014-4073-5", "24682996"]}, {"Citation": "Hagerman A. E., Butler L. G. (1981). The specificity of proanthocyanidin-protein interaction. J. Biol. Chem. 256 4494\u20134497.", "ArticleIdList": ["7217094"]}, {"Citation": "Hay A. J. (1992). The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein. Semin. Virol. 3 21\u201330. 10.1016/j.bmc.2015.06.030", "ArticleIdList": ["10.1016/j.bmc.2015.06.030", "26145819"]}, {"Citation": "Hayden F. G., Hay A. J. (1992). Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr. Top. Microbiol. Immunol. 176 119\u2013130. 10.1007/978-3-642-77011-1_8", "ArticleIdList": ["10.1007/978-3-642-77011-1_8", "1600749"]}, {"Citation": "Houser K., Subbarao K. (2015). Influenza vaccines: challenges and solutions. Cell Host Microbe 17 295\u2013300. 10.1016/j.chom.2015.02.012", "ArticleIdList": ["10.1016/j.chom.2015.02.012", "PMC4362519", "25766291"]}, {"Citation": "Ikematsu H., Kawai N. (2011). Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Rev. Anti Infect. Ther. 9 851\u2013857. 10.1586/eri.11.112", "ArticleIdList": ["10.1586/eri.11.112", "21973296"]}, {"Citation": "Ison M. G. (2015). Optimizing antiviral therapy for influenza: understanding the evidence. Expert Rev. Anti Infect. Ther. 13 417\u2013425. 10.1586/14787210.2015.1018183", "ArticleIdList": ["10.1586/14787210.2015.1018183", "25695406"]}, {"Citation": "Jepson R. G., Craig J. C. (2008). Cranberries for preventing urinary tract infections. Cochrane Database Syst. Rev. 10 1\u201380. 10.1002/14651858.CD001321.pub4", "ArticleIdList": ["10.1002/14651858.CD001321.pub4", "18253990"]}, {"Citation": "Krieger E., Koraimann G., Vriend G. (2002). Increasing the precision of comparative models with Yasara Nova - a self-parameterizing force field. Proteins 47 393\u2013402. 10.1002/prot.10104", "ArticleIdList": ["10.1002/prot.10104", "11948792"]}, {"Citation": "Krueger C. G., Reed J. D., Feliciano R. P., Howell A. B. (2013). Quantifying and characterizing proanthocyanidins in cranberries in relation to urinary tract health. Anal. Bioanal. Chem. 405 4385\u20134395. 10.1007/s00216-013-6750-3", "ArticleIdList": ["10.1007/s00216-013-6750-3", "23397091"]}, {"Citation": "Lafond K. E., Nair H., Rasooly M. H., Valente F., Booy R., Rahman M., et al. (2016). Global role and burden of influenza in pediatric respiratory hospitalizations, 1982\u20132012: a systematic analysis. PLoS Med. 13:e1001977. 10.1371/journal.pmed.1001977", "ArticleIdList": ["10.1371/journal.pmed.1001977", "PMC4807087", "27011229"]}, {"Citation": "Lipson S. M., Cohen P., Zhoul J., Burdowski A., Stotzky G. (2007). Cranberry cocktail juice, cranberry concentrates and proanthocyanidins reduce reoviruse infectivity titers in African green monkey kidney epithelial cell cultures. Mol. Nutr. Food Res. 51 752\u2013758. 10.1002/mnfr.200600276", "ArticleIdList": ["10.1002/mnfr.200600276", "17487927"]}, {"Citation": "Loregian A., Mercorelli B., Nannetti G., Compagnin C., Pal\u00f9 G. (2014). Antiviral strategies against influenza virus: towards new therapeutic approaches. Cell. Mol. Life Sci. 71 3659\u20133683. 10.1007/s00018-014-1615-2", "ArticleIdList": ["10.1007/s00018-014-1615-2", "24699705"]}, {"Citation": "Luganini A., Caposio P., Landolfo S., Gribaudo G. (2008). Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry. Antimicrob. Agents Chemother. 52 1111\u20131120. 10.1128/AAC.00987-07", "ArticleIdList": ["10.1128/AAC.00987-07", "PMC2258505", "18180342"]}, {"Citation": "Luganini A., Giuliani A., Pirri G., Pizzuto L., Landolfo S., Gribaudo G. (2010). Peptide-derivatized dendrimers inhibit human citomegalovirus infection by blocking virus binding to cell surface heparan sulfate. Antiviral Res. 85 532\u2013540. 10.1016/j.antiviral.2010.01.003", "ArticleIdList": ["10.1016/j.antiviral.2010.01.003", "20083141"]}, {"Citation": "McKimm-Breschkin J. L. (2002). Neuraminidase inhibitors for the treatment and prevention of influenza. Expert Opin. Pharmacother. 3 103\u2013112. 10.1517/14656566.3.2.103", "ArticleIdList": ["10.1517/14656566.3.2.103", "11829724"]}, {"Citation": "McKimm-Breschkin J. L. (2005). Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat. Respir. Med. 4 107\u2013116. 10.2165/00151829-200504020-00004", "ArticleIdList": ["10.2165/00151829-200504020-00004", "PMC7099216", "15813662"]}, {"Citation": "McKimm-Breschkin J. L. (2013). Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. Influenza Other Respir. Viruses 7 25\u201336. 10.1111/irv.12047", "ArticleIdList": ["10.1111/irv.12047", "PMC4942987", "23279894"]}, {"Citation": "Molinari N. A., Ortega-Sanchez I. R., Messonnier M. L., Thompsom W. W., Wortley P. M., Weintraub E., et al. (2007). The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25 5086\u20135096. 10.1016/j.vaccine.2007.03.046", "ArticleIdList": ["10.1016/j.vaccine.2007.03.046", "17544181"]}, {"Citation": "Mori S., Miyake S., Kobe T., Nakaya T., Fuller S. D., Kato N., et al. (2008). Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length. Bioorg. Med. Chem. Lett. 18 4249\u20134252. 10.1016/j.bmcl.2008.02.020", "ArticleIdList": ["10.1016/j.bmcl.2008.02.020", "18547804"]}, {"Citation": "Morris G. M., Goodsell D. S., Halliday R. S., Huey R., Hart W. E., Belew R. K., et al. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19 1639\u20131662. 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B", "ArticleIdList": ["10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B"]}, {"Citation": "Morris G. M., Huey R., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., et al. (2009). AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30 2785\u20132791. 10.1002/jcc.21256", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Occhipinti A., Germano A., Maffei M. E. (2016). Prevention of urinary tract infection with Oximacro\u00ae, a cranberry extract with a high content of a-type proanthocyanidins (PAC-A). A pre-clinical double-blind controlled study. Urol. J. 13 2640\u20132649.", "ArticleIdList": ["27085566"]}, {"Citation": "Oiknine-Djian E., Houri-Haddad Y., Weiss E. I., Ofek I., Greenbaum E., Hartshorn K., et al. (2012). High molecular weight constituents of cranberry interfere with influenza virus neuraminidase activity in vitro. Planta Med. 78 962\u2013967. 10.1055/s-0031-1298579", "ArticleIdList": ["10.1055/s-0031-1298579", "22588835"]}, {"Citation": "Paules C., Subbarao K. (2017). Influenza. Lancet 390 697\u2013708. 10.1016/S0140-6736(17)30129-0", "ArticleIdList": ["10.1016/S0140-6736(17)30129-0", "28302313"]}, {"Citation": "Prior R. L., Fan E., Ji H., Howell A., Nio C., Payne M. J., et al. (2010). Multi-laboratory validation of a standard method for quantifying proanthocyanidins in cranberry powders. J. Sci. Food Agric. 90 1473\u20131478. 10.1002/jsfa.3966", "ArticleIdList": ["10.1002/jsfa.3966", "20549799"]}, {"Citation": "Sekizawa H., Ikuta K., Mizuta K., Takechi S., Suzutani T. (2013). Relationships between polyphenol content and anti-influenza viral effects of berries. J. Sci. Food Agric. 93 2239\u20132241. 10.1002/jsfa.6031", "ArticleIdList": ["10.1002/jsfa.6031", "23355221"]}, {"Citation": "Shin I. S., Ku K. B., Jang Y., Yoon Y.-S., Shin D., Kwon O. S., et al. (2017). Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate. J. Microbiol. 55 979\u2013983. 10.1007/s12275-017-7371-x", "ArticleIdList": ["10.1007/s12275-017-7371-x", "29214495"]}, {"Citation": "Shmuely H., Ofek I., Weiss E. I., Rones Z., Houri-Haddad Y. (2012). Cranberry components for the therapy of infectious disease. Curr. Opin. Biotech. 23 148\u2013152. 10.1016/j.copbio.2011.10.009", "ArticleIdList": ["10.1016/j.copbio.2011.10.009", "22088310"]}, {"Citation": "Soares S. I., Gon\u00e7alves R. M., Fernandes I., Mateus N., de Freitas V. (2009). Mechanistic approach by which polysaccharides inhibit \u03b1-amylase/procyanidin aggregation. J. Agric. Food Chem. 57 4352\u20134358. 10.1021/jf900302r", "ArticleIdList": ["10.1021/jf900302r", "19378996"]}, {"Citation": "Song W., Si L., Ji S., Wang H., Fang X. M., Yu L. Y., et al. (2014). Uralsaponins M-Y, antiviral triterpenoid saponins from the roots of Glycyrrhiza uralensis. J. Nat. Prod. 77 1632\u20131643. 10.1021/np500253m", "ArticleIdList": ["10.1021/np500253m", "24957203"]}, {"Citation": "Su A., Amy X., Howell B., Doris B., D\u2019Souza H. (2010). The effect of cranberry juice and cranberry proanthocianidins on the infectivity of human enteric viral surrogates. Food Microbiol. 27 535\u2013540. 10.1016/j.fm.2010.01.001", "ArticleIdList": ["10.1016/j.fm.2010.01.001", "20417404"]}, {"Citation": "Sundararajana A., Ganapathya R., Huana L., Dunlapb J. R., Webbyc R. J., Kotwald G. J., et al. (2010). Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Res. 88 1\u20139. 10.1016/j.antiviral.2010.06.014", "ArticleIdList": ["10.1016/j.antiviral.2010.06.014", "PMC7114265", "20637243"]}, {"Citation": "Suzuki H., Saito R., Masuda H., Oshitani H., Sato M., Sato I. (2003). Emergence of amantadine-resistant influenza A viruses: epidemiological study. J. Infect. Chemother. 9 195\u2013200. 10.1007/s10156-003-0262-6", "ArticleIdList": ["10.1007/s10156-003-0262-6", "14513385"]}, {"Citation": "Takashita E., Fujisaki S., Shirakura M., Nakamura K., Kishida N., Kuwahara T., et al. (2016). Influenza a (H1N1) pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution. Euro Surveill. 21:30258. 10.2807/1560-7917.ES.2016.21.24.30258", "ArticleIdList": ["10.2807/1560-7917.ES.2016.21.24.30258", "27336226"]}, {"Citation": "Terlizzi M. E., Occhipinti A., Luganini A., Maffei M. E., Gribaudo G. (2016). Inhibition of herpes simplex type 1 and type 2 infections by Oximacro\u00ae, a cranberry extract with a high content of A-type proanthocyanidins (PACs-A). Antiviral Res. 132 154\u2013164. 10.1016/j.antiviral.2016.06.006", "ArticleIdList": ["10.1016/j.antiviral.2016.06.006", "27321663"]}, {"Citation": "Thompson W. W., Weintraub E., Dhankhar P., Cheng O. Y., Brammer L., Meltzer M. I., et al. (2009). Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir. Viruses 3 37\u201349. 10.1111/j.1750-2659.2009.00073.x", "ArticleIdList": ["10.1111/j.1750-2659.2009.00073.x", "PMC4986622", "19453440"]}, {"Citation": "Van de Wakker S. I., Fischer M. J. E., Oosting R. S. (2017). New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections. Eur. J. Pharmacol. 809 178\u2013190. 10.1016/j.ejphar.2017.05.038", "ArticleIdList": ["10.1016/j.ejphar.2017.05.038", "28533172"]}, {"Citation": "Wang X., Jia W., Zhao A., Wang X. (2006). Anti-influenza agents from plants and traditional Chinese medicine. Phytother. Res. 20 335\u2013341. 10.1002/ptr.1892", "ArticleIdList": ["10.1002/ptr.1892", "16619359"]}, {"Citation": "Weiss E. I., Houri-Haddad Y., Greenbaum E., Hochman N., Ofek I., Zakay-Rones Z. (2005). Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res. 66 9\u201312. 10.1016/j.antiviral.2004.12.011", "ArticleIdList": ["10.1016/j.antiviral.2004.12.011", "15781126"]}, {"Citation": "Yang Z. F., Bai L. P., Huang W. B., Li X. Z., Zhao S. S., Zhong N. S., et al. (2014). Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure\u2013activity relationship analysis. Fitoterapia. 93 47\u201353. 10.1016/j.fitote.2013.12.011", "ArticleIdList": ["10.1016/j.fitote.2013.12.011", "24370660"]}]}], "History": [{"Year": "2018", "Month": "5", "Day": "2"}, {"Year": "2018", "Month": "7", "Day": "23"}, {"Year": "2018", "Month": "8", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "8", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["30131793", "PMC6090095", "10.3389/fmicb.2018.01826"]}}]}